Posted in | News | Nanobusiness

Sidense Announces 1T-OTP Memory IP is Available for Customer Designs at 65nm Process Node

Sidense, a leading developer of Logic Non-Volatile Memory (LNVM) IP cores, today announced that its 1T-OTP one-time programmable (OTP) memory IP is available for customer designs at the 65nm process node. Sidense is the first embedded OTP vendor to announce high density (above 1 Mbit) product availability for both standard-logic and low-power 65nm implementation.

Sidense's OTP memory was selected for use in ParkerVision's 65nm d2p mobile handset solution. "ParkerVision selected the SiPROM architecture for its small size, low power, and speed of programming. We had need for onboard memory and wanted to add some programmability for future features without compromising on our existing size and cost targets. Because our product is used in mobile handsets, power and form factor are paramount," said Domingo Figueredo, VP of Engineering at ParkerVision. "The excellent support received from Sidense has helped us realize first-pass silicon success," he added.

"The low power, small footprint and high security of our 1T-OTP technology provide our customers with embedded non-volatile memory arrays that give them competitive cost and performance advantages," said Xerxes Wania, Sidense President and CEO. "In addition, our silicon-proven, 'foundry friendly' OTP lets designers choose from a wide range of foundries and processes for implementing their devices."

Sidense SiPROM NVM arrays, based on the Company's patented 1T-Fuse™ technology, have been silicon proven in 65nm for both standard-logic and low-power processes and are available in densities up to 8 Mbits. Memory arrays are available from 180nm down to 55nm at many popular foundries.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.